WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on passage of the One, Big, Beautiful Bill Act (OBBBA): “The ...

We hope you enjoyed the July break. We're back with a look at a new measles record, and what BIO's saying about the One, Big, Beautiful Bill Act, drug patents, and more. (873 words, 4 minutes, 21 ...

A busy week on Capitol Hill brought BIO Board member testimony and developments on issues where BIO’s advocacy remains hyper-focused, including PPRV, ORPHAN Cures, and vaccination. Plus, ACIP stirs ...

BIO hit the American road again, this time to Richmond, VA to meet with Virginia Bio, local entrepreneurs and patient advocates, and a company that's reshoring production of advanced pharmaceutical ...